1. Home
  2. MOD vs COGT Comparison

MOD vs COGT Comparison

Compare MOD & COGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Modine Manufacturing Company

MOD

Modine Manufacturing Company

HOLD

Current Price

$146.02

Market Cap

7.1B

ML Signal

HOLD

Logo Cogent Biosciences Inc.

COGT

Cogent Biosciences Inc.

HOLD

Current Price

$36.79

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOD
COGT
Founded
1916
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
6.5B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
MOD
COGT
Price
$146.02
$36.79
Analyst Decision
Strong Buy
Buy
Analyst Count
5
14
Target Price
$177.60
$32.08
AVG Volume (30 Days)
1.3M
2.4M
Earning Date
02-04-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
14.04
N/A
EPS
3.47
N/A
Revenue
$2,685,700,000.00
N/A
Revenue This Year
$19.10
N/A
Revenue Next Year
$15.40
N/A
P/E Ratio
$42.07
N/A
Revenue Growth
8.10
N/A
52 Week Low
$64.79
$3.72
52 Week High
$166.94
$43.73

Technical Indicators

Market Signals
Indicator
MOD
COGT
Relative Strength Index (RSI) 58.12 48.18
Support Level $122.21 $37.70
Resistance Level $150.75 $40.40
Average True Range (ATR) 8.05 1.93
MACD 2.76 0.09
Stochastic Oscillator 87.57 45.61

Price Performance

Historical Comparison
MOD
COGT

About MOD Modine Manufacturing Company

Modine Manufacturing Co provides thermal management solutions to diversified markets and customers. The company provides engineered heat transfer systems and heat transfer components for use in on- and off-highway original equipment manufacturer (OEM) vehicular applications in the United States. It offers powertrain cooling products, such as engine cooling assemblies, radiators, condensers, and charge air coolers; auxiliary cooling products, including power steering and transmission oil coolers. Its operating segments include Climate Solutions and Performance Technologies.

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

Share on Social Networks: